Status: Not yet recruiting
Preliminary Safety and Efficacy Study of Extracellular Vesicle Infusion in the Intervention of Age-related Phenotypes With Impaired Glucose Tolerance.
The objective of this exploratory study was to evaluate the initial safety of human mesenchymal stem cell-derived extracellular vesicle infusion in an age-related phenotype with impaired glucose tolerance
Participants needed: 20
Trial details
Age: 35-65Biological sex: AllType: InterventionalSponsor: BEAUTECHUpdated: Jul 19, 2024
Eligibility criteria
The subjects are between 35 and 65 years old (inclusive), regardless of gender; [+3]
The subject has a severe allergy or is allergic to any component used in cell cu... [+4]